Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $56.08 | 1 | 65.1% |
| Education | $30.01 | 2 | 34.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $56.08 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $18.09 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2017 | $56.08 | 1 | Novartis Pharmaceuticals Corporation ($56.08) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/15/2017 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $56.08 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 482 | 893 | $293,704 | $64,647 |
| 2022 | 14 | 726 | 1,362 | $320,025 | $74,259 |
| 2021 | 16 | 724 | 1,409 | $335,102 | $75,872 |
| 2020 | 15 | 652 | 1,570 | $318,467 | $62,161 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 156 | 324 | $82,487 | $21,805 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 107 | $41,919 | $11,319 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 81 | $27,338 | $7,215 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 45 | $40,050 | $5,975 | 14.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 44 | $31,064 | $4,367 | 14.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 23 | $11,868 | $3,120 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 71 | $11,832 | $2,836 | 24.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 31 | $14,012 | $2,823 | 20.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $9,630 | $2,064 | 21.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 21 | $7,613 | $1,027 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 19 | $4,222 | $989.78 | 23.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 42 | $5,594 | $446.90 | 8.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 35 | $4,116 | $379.07 | 9.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 19 | $604.20 | $159.60 | 26.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 12 | 16 | $1,355 | $121.76 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 153 | 359 | $85,326 | $25,335 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 62 | 112 | $42,396 | $12,266 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 87 | $27,440 | $7,729 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 41 | 41 | $24,600 | $5,285 | 21.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $24,106 | $4,355 | 18.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 17 | 40 | $27,450 | $4,198 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 89 | $14,186 | $3,657 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 38 | $16,051 | $2,965 | 18.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 19 | $9,794 | $2,641 | 27.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 27 | $9,708 | $1,408 | 14.5% |
About Dr. Isaac Yeboah, MD
Dr. Isaac Yeboah, MD is a Hematology & Oncology healthcare provider based in Marshfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2012. The National Provider Identifier (NPI) number assigned to this provider is 1164775102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isaac Yeboah, MD has received a total of $86.09 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($56.08).
As a Medicare-enrolled provider, Yeboah has provided services to 2,584 Medicare beneficiaries, totaling 5,234 services with total Medicare billing of $276,939. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Marshfield, WI
- Active Since 10/15/2012
- Last Updated 04/02/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1164775102
Products in Payments
- KYMRIAH (Biological) $56.08
- WELIREG (Drug) $18.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Marshfield
Seth Fagbemi, Md, MD
Hematology & Oncology — Payments: $3,346
Chady Abboud Leon, M.d, M.D
Hematology & Oncology — Payments: $164.78
Lawrence Clouse, Md, MD
Hematology & Oncology
William Hocking, Md, MD
Hematology & Oncology
Moira Lancelot
Hematology & Oncology
Dr. Joseph Edmund, M.b.b.s, M.B.B.S
Hematology & Oncology